Jyoti Malhotra Selected Research

Type 1 Generalized Epilepsy With Febrile Seizures Plus

12/2002

Functional and biochemical analysis of a sodium channel beta1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jyoti Malhotra Research Topics

Disease

29	Neoplasms (Cancer) 11/2022 - 04/2011
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 04/2016
7	Lung Neoplasms (Lung Cancer) 03/2022 - 12/2015
3	Pneumonia (Pneumonitis) 01/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 07/2022 - 10/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 05/2021
2	Human Influenza (Influenza) 01/2022 - 01/2020
2	Diarrhea 05/2021 - 10/2019
2	Disease Progression 05/2021 - 01/2021
2	Inflammation (Inflammations) 03/2021 - 11/2019
2	Infections 03/2021 - 01/2020
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 01/2021
2	Carcinogenesis 10/2016 - 03/2015
2	Breast Neoplasms (Breast Cancer) 12/2015 - 07/2014
1	Adenocarcinoma of Lung 03/2022
1	COVID-19 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Clinical Deterioration 01/2022
1	Testicular Neoplasms (Testicular Cancer) 11/2021
1	Anemia 05/2021
1	Dyspnea (Shortness of Breath) 05/2021
1	Neutropenia 05/2021
1	Respiratory Insufficiency (Respiratory Failure) 05/2021
1	Hypophosphatemia 05/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2021
1	Headache (Headaches) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Vomiting 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Exanthema (Rash) 10/2019
1	Hyperglycemia 10/2019
1	Nausea 10/2019
1	Fatigue 10/2019
1	Anorexia 10/2019

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2015
4	Biomarkers (Surrogate Marker)IBA 03/2021 - 03/2015
3	Carboplatin (JM8)FDA LinkGeneric 11/2022 - 04/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2014
3	RNA (Ribonucleic Acid)IBA 03/2021 - 10/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 01/2022
2	DystrophinIBA 01/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 04/2011
2	pembrolizumabIBA 01/2020 - 04/2017
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2019 - 01/2019
2	TIC10 compoundIBA 01/2019 - 08/2017
2	Bortezomib (Velcade)FDA Link 06/2014 - 04/2011
1	talazoparibIBA 11/2022
1	Biological ProductsIBA 07/2022
1	Riluzole FDA LinkGeneric 07/2022
1	Glutamic Acid (Glutamate)FDA Link 07/2022
1	ProdrugsIBA 07/2022
1	NivolumabIBA 07/2022
1	Fibrinogen (Factor I)FDA Link 03/2022
1	1- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA 01/2022
1	Topoisomerase InhibitorsIBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	CytokinesIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	veliparibIBA 01/2022
1	montelukast (Singulair)FDA Link 01/2022
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2022
1	PlatinumIBA 01/2022
1	AntigensIBA 11/2021
1	Protein Subunit VaccinesIBA 11/2021
1	glembatumumab vedotinIBA 05/2021
1	Alanine Transaminase (SGPT)IBA 05/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2021
1	Glycoproteins (Glycoprotein)IBA 05/2021
1	isochorismataseIBA 03/2021
1	Small Interfering RNA (siRNA)IBA 03/2021
1	osimertinibIBA 01/2021
1	eteplirsenIBA 01/2021
1	golodirsenIBA 01/2021
1	navitoclaxIBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021
1	Dinoprostone (PGE2)FDA Link 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	thiamine triphosphorate (TTP)IBA 10/2020
1	Cyclooxygenase InhibitorsIBA 10/2020
1	SqualeneIBA 01/2020
1	VaccinesIBA 01/2020
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020
1	Indicators and Reagents (Reagents)IBA 11/2019
1	MK 2206IBA 10/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019

Therapy/Procedure

12	Therapeutics 07/2022 - 01/2018
7	Immunotherapy 06/2022 - 04/2017
6	Radiotherapy 01/2021 - 12/2012
5	Drug Therapy (Chemotherapy) 06/2022 - 12/2012
2	Aftercare (After-Treatment) 03/2022 - 04/2011
2	Chemoradiotherapy 01/2020 - 04/2016
1	Length of Stay 01/2022
1	Contraindications 01/2020
1	Intramuscular Injections 01/2020
1	Oral Administration 01/2019